http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-107801-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
filingDate 2010-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ce955490e685b6c5d8c7e4a7fe8ed4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f635bb33ac885bbd32a2e3f7b89639dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952982885aec286344cef45bcea29a7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f1cb0ec67ca9b141a74e95b65ccbda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0c20f623041ca949d60791fd7f63ca0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844b5da61a905f67cfead1adec233bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32165ccc7d857a160c875bae8f30fd71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb0fbb207bedf63f087265120d68886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f1539eb8de9e3d018d9f8cc2237a59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9932fbaada50f0cf74da661ce0fb82da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d1868112bf5302462b612e02d8f5160
publicationDate 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-107801-C2
titleOfInvention THIOPHENE-2-CARBIC ACID DERIVATIVES AS FLAVIVIRIDAE VIRUS INHIBITORS
abstract The compounds of Formula (I) and their pharmaceutically acceptable salts and esters are presented. The compounds and compositions presented are useful in the treatment of Flaviviridae viral infections, especially hepatitis C infections.
priorityDate 2009-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582519

Total number of triples: 30.